title: Evolution of advanced technologies in prostate cancer radiotherapy.
abstract: Conventional treatment options for clinically localized, low-risk prostate cancer include radical prostatectomy, external-beam radiotherapy (EBRT) and low-dose-rate brachytherapy. Advances in image-guided radiotherapy (IGRT) since the 1980s, the development of intensity-modulated radiotherapy (IMRT) during the 1990s and evidence from radiobiological models--which support the use of high doses per fraction--have developed alongside novel advanced radiotherapy modalities that include high-dose-rate brachytherapy (HDR-BT), stereotactic body radiotherapy (SBRT) and proton beam therapy. The relationship between the outcomes of and toxicities experienced by patients with prostate cancer treated with HDR-BT, SBRT and particle-beam therapy should provide urologists and oncologists an understanding of the continually evolving technology in prostate radiotherapy. On the basis of published evidence, conventionally fractionated EBRT with IMRT is considered the standard of care over conventional 3D conformal radiotherapy, whereas HDR-BT boost is an acceptable treatment option for selected patients with intermediate-risk and high-risk prostate cancer. SBRT and proton therapy should not be used for patients (regardless of disease risk group) outside the setting of a clinical trial. Finally, comparative effectiveness research should be conducted to provide a framework for evaluating advanced radiotherapy technologies by comparing the benefits and harms of available therapeutic options to optimize the risk:benefit ratio and improve cost effectiveness.
authors.affiliation: Department of Radiation Oncology, Fox Chase Cancer Center, 333 Cottman Avenue, Philadelphia, PA 19111, USA.
authors.forename: Nicholas G
authors.initials: NG
authors.lastname: Zaorsky
authors.forename: Amy S
authors.initials: AS
authors.lastname: Harrison
authors.forename: Edouard J
authors.initials: EJ
authors.lastname: Trabulsi
authors.forename: Leonard G
authors.initials: LG
authors.lastname: Gomella
authors.forename: Timothy N
authors.initials: TN
authors.lastname: Showalter
authors.forename: Mark D
authors.initials: MD
authors.lastname: Hurwitz
authors.forename: Adam P
authors.initials: AP
authors.lastname: Dicker
authors.forename: Robert B
authors.initials: RB
authors.lastname: Den
mesh_terms: D000818:Animals; D006801:Humans; D008297:Male; D011471:Prostatic Neoplasms / Q000175:diagnosis / Q000532:radiotherapy* / Q000601:surgery*; D016634:Radiosurgery / Q000379:methods / Q000639:trends*; D020266:Radiotherapy, Conformal / Q000379:methods / Q000639:trends; D061089:Radiotherapy, Image-Guided / Q000379:methods / Q000639:trends*
references.citation: Jpn J Clin Oncol. 2009 Nov;39(11):732-8
references.pmid: 19666904
references.citation: Clin Oncol (R Coll Radiol). 2012 Sep;24(7):461-73
references.pmid: 22673744
references.citation: Int J Radiat Oncol Biol Phys. 1995 Apr 30;32(1):3-12
references.pmid: 7721636
references.citation: Med Phys. 2008 Sep;35(9):4041-8
references.pmid: 18841856
references.citation: Pharmacoeconomics. 2010;28(10):905-13
references.pmid: 20831298
references.citation: Int J Radiat Oncol Biol Phys. 2013 Sep 1;87(1):81-7
references.pmid: 23414766
references.citation: BMJ. 1999 Sep 11;319(7211):652-3
references.pmid: 10480802
references.citation: Int J Radiat Oncol Biol Phys. 1993 Apr 2;25(5):895-906
references.pmid: 8478242
references.citation: J Natl Compr Canc Netw. 2010 Feb;8(2):145
references.pmid: 20141674
references.citation: Int J Radiat Oncol Biol Phys. 2008 Mar 1;70(3):847-52
references.pmid: 18262098
references.citation: Expert Rev Anticancer Ther. 2011 Jul;11(7):1033-9
references.pmid: 21806327
references.citation: Cancer Treat Rev. 2013 May;39(3):212-8
references.pmid: 23218442
references.citation: J Natl Cancer Inst. 2013 Jan 2;105(1):7-8
references.pmid: 23243201
references.citation: Semin Urol Oncol. 1997 Nov;15(4):239-43
references.pmid: 9421451
references.citation: Int J Radiat Oncol Biol Phys. 2010 Feb 1;76(2):326-32
references.pmid: 20117285
references.citation: Adv Urol. 2012;2012:368528
references.pmid: 22190918
references.citation: Clin Oncol (R Coll Radiol). 2013 Aug;25(8):483-98
references.pmid: 23810749
references.citation: BJU Int. 2012 Feb;109 Suppl 1:22-9
references.pmid: 22239226
references.citation: Radiother Oncol. 2012 May;103(2):206-9
references.pmid: 22385796
references.citation: Eur Urol. 2011 Nov;60(5):908-16
references.pmid: 21684064
references.citation: Acta Oncol. 2003;42(5-6):411-5
references.pmid: 14596503
references.citation: J Urol. 2003 Mar;169(3):974-9; discussion 979-80
references.pmid: 12576825
references.citation: Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1099-105
references.pmid: 17336216
references.citation: Technol Cancer Res Treat. 2010 Dec;9(6):575-82
references.pmid: 21070079
references.citation: Radiother Oncol. 2011 Sep;100(3):436-41
references.pmid: 21963289
references.citation: Expert Rev Anticancer Ther. 2009 Jan;9(1):61-5
references.pmid: 19105707
references.citation: Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):e173-9
references.pmid: 22857886
references.citation: Semin Nucl Med. 2011 Jan;41(1):29-44
references.pmid: 21111858
references.citation: JAMA. 2012 Apr 18;307(15):1611-20
references.pmid: 22511689
references.citation: Int J Radiat Oncol Biol Phys. 2011 Feb 1;79(2):363-70
references.pmid: 21195875
references.citation: Int J Radiat Oncol Biol Phys. 2002 Jan 1;52(1):6-13
references.pmid: 11777617
references.citation: Int J Radiat Oncol Biol Phys. 2012 Oct 1;84(2):318-22
references.pmid: 22436790
references.citation: Am J Clin Oncol. 1993 Apr;16(2):164-7
references.pmid: 8452112
references.citation: Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1019-34
references.pmid: 15752881
references.citation: Curr Urol Rep. 2011 Jun;12(3):237-42
references.pmid: 21399887
references.citation: Eur Urol. 2009 Apr;55(4):801-14
references.pmid: 19185981
references.citation: Int J Radiat Oncol Biol Phys. 2012 Aug 1;83(5):1655-60
references.pmid: 22572080
references.citation: Radiother Oncol. 2012 Dec;105(3):321-8
references.pmid: 23075580
references.citation: Int J Radiat Oncol Biol Phys. 2009 Jan 1;73(1):9-14
references.pmid: 19100920
references.citation: Eur Urol. 2011 Jun;59(6):962-77
references.pmid: 21367519
references.citation: Cancer. 2012 Aug 1;118(15):3681-90
references.pmid: 22170628
references.citation: Acta Oncol. 2007;46(7):909-17
references.pmid: 17917823
references.citation: Nat Rev Urol. 2012 Apr 10;9(5):258-65
references.pmid: 22487871
references.citation: Radiother Oncol. 2012 May;103(2):256-60
references.pmid: 22197354
references.citation: Int J Radiat Oncol Biol Phys. 2002 Nov 1;54(3):824-9
references.pmid: 12377335
references.citation: Int J Radiat Oncol Biol Phys. 2009 Aug 1;74(5):1405-18
references.pmid: 19616743
references.citation: J Clin Oncol. 2011 May 20;29(15):2020-6
references.pmid: 21464418
references.citation: Brachytherapy. 2013 Jan-Feb;12(1):30-7
references.pmid: 22727474
references.citation: Int J Radiat Oncol Biol Phys. 2010 Apr;76(5):1295-6
references.pmid: 20338472
references.citation: Int J Radiat Oncol Biol Phys. 2011 Mar 1;79(3):909-14
references.pmid: 20732764
references.citation: Strahlenther Onkol. 2004 Sep;180(9):582-9
references.pmid: 15378189
references.citation: Acta Oncol. 2013 Jun;52(5):902-9
references.pmid: 23327339
references.citation: Brachytherapy. 2006 Oct-Dec;5(4):256-61
references.pmid: 17118320
references.citation: Radiother Oncol. 2013 Jun;107(3):372-6
references.pmid: 23719583
references.citation: Brachytherapy. 2012 Jul-Aug;11(4):292-8
references.pmid: 22464911
references.citation: Int J Radiat Oncol Biol Phys. 2005 Apr 1;61(5):1306-16
references.pmid: 15817332
references.citation: Oncology (Williston Park). 2010 May;24(6):542-3
references.pmid: 20568596
references.citation: Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):635-42
references.pmid: 21377294
references.citation: Int J Radiat Oncol Biol Phys. 2008 Nov 15;72(4):980-8
references.pmid: 18495377
references.citation: Cancer Control. 2007 Jul;14(3):238-43
references.pmid: 17615529
references.citation: Prostate Cancer. 2012;2012:130579
references.pmid: 22111005
references.citation: Future Oncol. 2012 Jan;8(1):37-54
references.pmid: 22149034
references.citation: J Natl Cancer Inst. 2013 Jan 2;105(1):6-7
references.pmid: 23243200
references.citation: Curr Opin Urol. 2010 May;20(3):223-8
references.pmid: 20179597
references.citation: Int J Radiat Oncol Biol Phys. 2006 Oct 1;66(2):416-23
references.pmid: 16879929
references.citation: NCI Monogr. 1988;(7):75-84
references.pmid: 3050542
references.citation: Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):877-82
references.pmid: 21300474
references.citation: Prostate Cancer Prostatic Dis. 2007;10(3):288-92
references.pmid: 17160068
references.citation: Radiother Oncol. 1999 Apr;51(1):43-53
references.pmid: 10386716
references.citation: Brachytherapy. 2012 Nov-Dec;11(6):441-5
references.pmid: 22728157
references.citation: Eur Urol. 2013 Dec;64(6):895-902
references.pmid: 23541457
references.citation: Clin Oncol (R Coll Radiol). 2008 Dec;20(10):729-37
references.pmid: 18838256
references.citation: Brachytherapy. 2012 Jan-Feb;11(1):20-32
references.pmid: 22265435
references.citation: Eur Urol. 2013 Mar;63(3):428-35
references.pmid: 23084329
references.citation: Int J Clin Oncol. 2009 Feb;14(1):31-6
references.pmid: 19225921
references.citation: Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):e593-9
references.pmid: 22836050
references.citation: Int J Radiat Oncol Biol Phys. 2011 Nov 15;81(4):e325-34
references.pmid: 21498008
references.citation: Am J Med. 2010 Dec;123(12 Suppl 1):e16-23
references.pmid: 21184862
references.citation: Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):125-9
references.pmid: 22330997
references.citation: Int J Radiat Oncol Biol Phys. 2013 Mar 15;85(4):e173-7
references.pmid: 23245278
references.citation: Cancer. 2013 May 1;119(9):1729-35
references.pmid: 23436283
references.citation: Radiology. 1946 Nov;47(5):487-91
references.pmid: 20274616
references.citation: Am J Clin Oncol. 2010 Oct;33(5):481-8
references.pmid: 19952715
references.citation: Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1529-36
references.pmid: 17544595
references.citation: Int J Radiat Oncol Biol Phys. 2006 Jan 1;64(1):289-300
references.pmid: 16377417
references.citation: J Endourol. 2010 May;24(5):781-9
references.pmid: 20370439
references.citation: Int J Radiat Oncol Biol Phys. 2011 Aug 1;80(5):1589-600
references.pmid: 21167651
references.citation: Radiother Oncol. 2012 May;103(2):217-22
references.pmid: 22341794
references.citation: Phys Med Biol. 2010 Jan 7;55(1):65-82
references.pmid: 19949260
references.citation: Cancer. 2012 Nov 15;118(22):5535-43
references.pmid: 22544661
references.citation: Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):388-91
references.pmid: 19056185
references.citation: Int J Radiat Oncol Biol Phys. 2008 Jul 15;71(4):979-86
references.pmid: 18325681
references.citation: Semin Radiat Oncol. 2008 Oct;18(4):249-56
references.pmid: 18725112
references.citation: Br J Cancer. 2013 Apr 2;108(6):1225-30
references.pmid: 23481182
references.citation: Eur Urol. 2011 Dec;60(6):1133-9
references.pmid: 21889832
references.citation: Eur Urol. 2012 Jun;61(6):1079-92
references.pmid: 22424666
references.citation: Int J Radiat Oncol Biol Phys. 2012 Sep 1;84(1):130-6
references.pmid: 22330987
references.citation: J Clin Oncol. 2010 Mar 1;28(7):1106-11
references.pmid: 20124169
references.citation: Med Dosim. 2012 Winter;37(4):396-400
references.pmid: 22534137
references.citation: Semin Radiat Oncol. 2008 Jan;18(1):67-72
references.pmid: 18082590
references.citation: Radiother Oncol. 2013 May;107(2):207-12
references.pmid: 23541644
references.citation: Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):522-35
references.pmid: 12957266
references.citation: Int J Radiat Oncol Biol Phys. 2003 Jul 15;56(4):1093-104
references.pmid: 12829147
references.citation: J Clin Oncol. 2010 Sep 20;28(27):4275-9
references.pmid: 20697074
references.citation: Med Phys. 2012 Jun;39(6):3189-201
references.pmid: 22755703
references.citation: Med Phys. 2012 Aug;39(8):4807-11
references.pmid: 22894406
references.citation: Trials. 2011 Dec 05;12:255
references.pmid: 22141598
references.citation: Int J Radiat Oncol Biol Phys. 2012 Feb 1;82(2):e201-9
references.pmid: 21621343
references.citation: Int J Radiat Oncol Biol Phys. 2005 Jul 15;62(4):965-73
references.pmid: 15989996
references.citation: JAMA. 2005 Sep 14;294(10):1233-9
references.pmid: 16160131
references.citation: Cancer Treat Rev. 2013 Nov;39(7):728-36
references.pmid: 23453861
references.citation: Health Technol Assess. 2010 Oct;14(47):1-108, iii-iv
references.pmid: 21029717
references.citation: Int J Radiat Oncol Biol Phys. 2005 Nov 15;63(4):1153-60
references.pmid: 15990247
references.citation: Expert Rev Anticancer Ther. 2014 Jan;14(1):39-50
references.pmid: 24124755
references.citation: Am J Clin Oncol. 2009 Aug;32(4):342-7
references.pmid: 19398902
references.citation: Cancer. 2011 Dec 15;117(24):5589-600
references.pmid: 21692058
references.citation: Radiother Oncol. 2007 Aug;84(2):156-63
references.pmid: 17692976
references.citation: Med Phys. 2012 Jun;39(6):3291-8
references.pmid: 22755712
references.citation: Radiother Oncol. 2007 Aug;84(2):128-34
references.pmid: 17561293
references.citation: Int J Radiat Oncol Biol Phys. 1997 Jan 1;37(1):21-9
references.pmid: 9054873
references.citation: Int J Radiat Oncol Biol Phys. 2008 Jun 1;71(2):330-7
references.pmid: 18164858
references.citation: J Intern Med. 2012 Apr;271(4):353-65
references.pmid: 22308973
references.citation: Int J Radiat Oncol Biol Phys. 2001 Jul 15;50(4):1021-31
references.pmid: 11429230
references.citation: Int J Radiat Oncol Biol Phys. 2007 Apr 1;67(5):1418-24
references.pmid: 17241751
references.citation: Int J Radiat Oncol Biol Phys. 2009 Dec 1;75(5):1613-20
references.pmid: 19836164
references.citation: Radiother Oncol. 2000 Jun;55(3):251-62
references.pmid: 10869740
references.citation: Clin Oncol (R Coll Radiol). 2010 Oct;22(8):698-706
references.pmid: 20688494
references.citation: Radiother Oncol. 2009 Oct;93(1):137-40
references.pmid: 19732984
references.citation: JAMA. 2004 Jun 9;291(22):2713-9
references.pmid: 15187052
references.citation: Int J Radiat Oncol Biol Phys. 2012 Jan 1;82(1):213-21
references.pmid: 21093164
references.citation: Prostate. 2004 Feb 15;58(3):252-8
references.pmid: 14743464
references.citation: Med Dosim. 2011 Summer;36(2):188-94
references.pmid: 21540013
references.citation: Int J Radiat Oncol Biol Phys. 2010 Nov 1;78(3):773-80
references.pmid: 20153122
references.citation: Lancet Oncol. 2007 Jun;8(6):475-87
references.pmid: 17482880
references.citation: Radiother Oncol. 2006 Oct;81(1):57-64
references.pmid: 16971008
references.citation: Int J Radiat Oncol Biol Phys. 2011 Dec 1;81(5):1286-92
references.pmid: 21310546
references.citation: Semin Oncol. 2013 Jun;40(3):308-21
references.pmid: 23806496
references.citation: Strahlenther Onkol. 2006 Mar;182(3):135-41
references.pmid: 16520907
references.citation: J Urol. 2007 Jun;177(6):2106-31
references.pmid: 17509297
references.citation: Int J Radiat Oncol Biol Phys. 2013 Jan 1;85(1):230-6
references.pmid: 22554583
references.citation: Radiother Oncol. 2011 Jan;98(1):74-80
references.pmid: 21176983
references.citation: Int J Radiat Oncol Biol Phys. 2008 Jan 1;70(1):67-74
references.pmid: 17765406
references.citation: Semin Radiat Oncol. 2007 Oct;17(4):258-67
references.pmid: 17903703
references.citation: Int J Urol. 2012 Apr;19(4):296-305
references.pmid: 22320843
references.citation: Int J Radiat Oncol Biol Phys. 2005 Mar 15;61(4):1258-66
references.pmid: 15752908
references.citation: Clin Oncol (R Coll Radiol). 2011 Jun;23(5):344-9
references.pmid: 21353504
references.citation: Radiother Oncol. 2009 May;91(2):217-24
references.pmid: 19136175